Amgen 2006 Annual Report Download - page 30

Download and view the complete annual report

Please find page 30 of the 2006 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 38

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38

Amgen 2006 Annual Report 28
Consolidated Statement of Operations Data—GAAP*
(In millions, except per share data)
Years ended December 31, 2006 2005 2004 2003 2002
Revenues:
Product sales $ 13,858 $ 12,022 $ 9,977 $ 7,868 $ 4,991
Other revenues 410 408 573 488 532
Total revenues 14,268 12,430 10,550 8,356 5,523
Operating expenses:
Cost of sales (excludes amortization of acquired intangible
assets presented below) 2,095 2,082 1,731 1,341 736
Research and development 3,366 2,314 2,028 1,655 1,117
Write-off of acquired in-process research and development 1,231 554 — 2,992
Selling, general and administrative 3,366 2,790 2,556 1,957 1,449
Amortization of acquired intangible assets 370 347 333 336 155
Other items, net 49 (24) (141)
Net income (loss) 2,950 3,674 2,363 2,259 (1,392)
Diluted earnings (loss) per share 2.48 2.93 1.81 1.69 (1.21)
Consolidated Balance Sheet Data—GAAP*
(In millions)
At December 31, 2006 2005 2004 2003 2002
Cash and marketable securities $ 6,277 $ 5,255 $ 5,808 $ 5,123 $ 4,664
Total assets 33,788 29,297 29,221 26,113 24,456
Total debt 9,012 3,957 3,937 3,080 3,048
Stockholders’ equity 18,964 20,451 19,705 19,389 18,286
Common stock outstanding 1,166 1,224 1,260 1,284 1,289
Note: The above selected financial information is only a summary and should be read in conjunction with, and is qualified by reference to, our consolidated financial statements and related notes
in our Annual Reports on Form 10-K filed with the Securities and Exchange Commission for the years presented.
*In accordance with generally accepted accounting principles in the United States.
Selected Financial Information
Total revenues
($ in millions)
2006 $14,268
2005 12,430
2004 10,550
2003 8,356
2002 5,523
04 05 060302